This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sonenshein, A L Articles by Fisher, S H Search for Related Content PubMed PubMed Citation Articles by Sonenshein, A L Articles by Fisher, S H

 Previous Article  |  Next Article 

J Bacteriol. 1977 October; 132(1): 73-79

Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis.

ABSTRACT

Lipiarmycin inhibited the activity of deoxyribonucleic acid-dependent ribonucleic acid (RNA) polymerase in vitro. We showed that inhibition was due to interference by lipiarmycin with the activity of sigma-containing molecules of RNA polymerase. Transcription by core enzyme was relatively resistant to the drug, but addition of sigma led to highly drug-sensitive RNA synthesis. We isolated lipiarmycin-resistant mutants of Bacillus subtilis and characterized them genetically and biochemically. Drug-resistant mutants contained an altered RNA polymerase that was resistant to the drug in vitro. By separation and mixed reconstitution of core and sigma fractions of mutant and wild-type RNA polymerase, we showed that lipiarmycin resistance in one mutant strain was a property of the core fraction. Genetic mapping experiments indicated that at least two lpm mutants are located between loci determining rifampin resistance and streptolydigin resistance.

This article has been cited by other articles:

• Gualtieri, M., Villain-Guillot, P., Latouche, J., Leonetti, J.-P., Bastide, L. (2006). Mutation in the Bacillus subtilis RNA Polymerase {beta}' Subunit Confers Resistance to Lipiarmycin. Antimicrob. Agents Chemother. 50: 401-402 [Full Text]